Literature DB >> 20186429

Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome.

Kari Lima1, Ivar Følling, Kristin L Eiklid, Solveig Natvig, Tore G Abrahamsen.   

Abstract

Patients with the 22q11.2 deletion syndrome display a wide phenotypic variation that is important for clinical follow-up. In this national survey of 60 patients (ages 1 to 54 years) diagnosed by Fluorescence in situ hybridization test, data were collected from medical records, a physical examination, and a semistructured interview. Ultrasound investigation of the kidneys was also performed. In addition, multiplex ligation probe amplification assay was performed to detect deletion size. Phenotypic features leading to the genetic diagnosis were noted. The patients showed a variety of organ malformations including 39 with heart anomalies. Only 20 individuals had been diagnosed with 22q11.2 DS in the first year of life. Four patients had renal and five males had genital malformations. The increased infection susceptibility (excluding otitis media) and most feeding difficulties subsided during early childhood. Speech difficulties started early and were a major problem for many patients at least until 10 years of age. Ten patients developed kyphoscoliosis in late childhood. In teenagers and adults, abnormal social behavior, learning disabilities, and psychiatric symptoms dominated. Our study which also includes adult patients emphasizes a marked change in challenges in individuals with the 22q11.2 deletion syndrome with increasing age.

Entities:  

Mesh:

Year:  2010        PMID: 20186429     DOI: 10.1007/s00431-010-1161-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  Birthweight by gestational age in Norway.

Authors:  R Skjaerven; H K Gjessing; L S Bakketeig
Journal:  Acta Obstet Gynecol Scand       Date:  2000-06       Impact factor: 3.636

2.  Distal 22q11.2 microduplication encompassing the BCR gene.

Authors:  Maria Descartes; Judy Franklin; Teresita Diaz de Ståhl; Arkadiusz Piotrowski; Carl E G Bruder; Jan P Dumanski; Andrew J Carroll; Fady M Mikhail
Journal:  Am J Med Genet A       Date:  2008-12-01       Impact factor: 2.802

3.  Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  A F Jawad; D M McDonald-Mcginn; E Zackai; K E Sullivan
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

4.  Decreased thymus size in formula-fed infants compared with breastfed infants.

Authors:  H Hasselbalch; D L Jeppesen; M D Engelmann; K F Michaelsen; M B Nielsen
Journal:  Acta Paediatr       Date:  1996-09       Impact factor: 2.299

Review 5.  The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.

Authors:  A Swillen; K Devriendt; E Legius; P Prinzie; A Vogels; P Ghesquière; J P Fryns
Journal:  Genet Couns       Date:  1999

6.  Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.

Authors:  Lena Niklasson; Peder Rasmussen; Sólveig Oskarsdóttir; Christopher Gillberg
Journal:  Dev Med Child Neurol       Date:  2002-01       Impact factor: 5.449

7.  Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.

Authors:  A R Gennery; D Barge; J J O'Sullivan; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

8.  Prevalence of duplications and deletions of the 22q11 DiGeorge syndrome region in a population-based sample of infants with cleft palate.

Authors:  Ase Sivertsen; Rolv Terje Lie; Allen J Wilcox; Frank Abyholm; Hallvard Vindenes; Bjørn Ivar Haukanes; Gunnar Houge
Journal:  Am J Med Genet A       Date:  2007-01-15       Impact factor: 2.802

Review 9.  Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes.

Authors:  Lisa J Kobrynski; Kathleen E Sullivan
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

10.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

View more
  14 in total

1.  Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome.

Authors:  Dina M Aresvik; Torstein Øverland; Kari Lima; Rolf D Pettersen; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2018-12-19       Impact factor: 8.317

Review 2.  Head and neck manifestations of 22q11.2 deletion syndromes.

Authors:  Tal Marom; Yehudah Roth; Abraham Goldfarb; Udi Cinamon
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-23       Impact factor: 2.503

3.  Gastrointestinal Features of 22q11.2 Deletion Syndrome Include Chronic Motility Problems From Childhood to Adulthood.

Authors:  Rebecca E Kotcher; Daniel B Chait; Jason M Heckert; T Blaine Crowley; Kimberly A Forde; Nitin K Ahuja; Maria R Mascarenhas; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn; James C Reynolds
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-06-01       Impact factor: 3.288

Review 4.  The 22q11.2 Microdeletion in Pediatric Patients with Cleft Lip, Palate, or Both and Congenital Heart Disease: A Systematic Review.

Authors:  Diana Cárdenas-Nieto; Maribel Forero-Castro; Clara Esteban-Pérez; Julio Martínez-Lozano; Ignacio Briceño-Balcázar
Journal:  J Pediatr Genet       Date:  2019-10-23

5.  Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.

Authors:  A Legitimo; V Bertini; G Costagliola; G I Baroncelli; R Morganti; A Valetto; R Consolini
Journal:  Clin Exp Immunol       Date:  2020-04-16       Impact factor: 4.330

6.  Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.

Authors:  Mariela Mosheva; Virginie Pouillard; Yael Fishman; Lydia Dubourg; Dafna Sofrin-Frumer; Yaffa Serur; Abraham Weizman; Stephan Eliez; Doron Gothelf; Maude Schneider
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-22       Impact factor: 4.785

7.  Functional outcomes of adults with 22q11.2 deletion syndrome.

Authors:  Nancy J Butcher; Eva W C Chow; Gregory Costain; Dominique Karas; Andrew Ho; Anne S Bassett
Journal:  Genet Med       Date:  2012-06-28       Impact factor: 8.822

8.  A defect in early myogenesis causes Otitis media in two mouse models of 22q11.2 Deletion Syndrome.

Authors:  Jennifer C Fuchs; Jennifer F Linden; Antonio Baldini; Abigail S Tucker
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

9.  Dysphagia and disrupted cranial nerve development in a mouse model of DiGeorge (22q11) deletion syndrome.

Authors:  Beverly A Karpinski; Thomas M Maynard; Matthew S Fralish; Samer Nuwayhid; Irene E Zohn; Sally A Moody; Anthony-S LaMantia
Journal:  Dis Model Mech       Date:  2013-12-19       Impact factor: 5.758

10.  Towards a safety net for management of 22q11.2 deletion syndrome: guidelines for our times.

Authors:  Alex Habel; Richard Herriot; Dinakantha Kumararatne; Jeremy Allgrove; Kate Baker; Helen Baxendale; Frances Bu'Lock; Helen Firth; Andrew Gennery; Anthony Holland; Claire Illingworth; Nigel Mercer; Merel Pannebakker; Andrew Parry; Anne Roberts; Beverly Tsai-Goodman
Journal:  Eur J Pediatr       Date:  2014-01-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.